
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE)
Meredith Y. Smith, Elaine H. Morrato, Nallely Mora, et al.
Drug Safety (2024) Vol. 47, Iss. 7, pp. 655-671
Open Access | Times Cited: 4
Meredith Y. Smith, Elaine H. Morrato, Nallely Mora, et al.
Drug Safety (2024) Vol. 47, Iss. 7, pp. 655-671
Open Access | Times Cited: 4
Showing 4 citing articles:
Using Mixed Methods to Evaluate Risk Minimisation Programs in Europe and the USA: An Innovative Blueprint
Meredith Y. Smith, Rachel Davis, Priya Bahri, et al.
Drug Safety (2025)
Open Access
Meredith Y. Smith, Rachel Davis, Priya Bahri, et al.
Drug Safety (2025)
Open Access
Duration of Time Intervals for Risk Minimization Measure Effectiveness Studies
Sharon Essink, Inge M. Zomerdijk, Thomas Goedecke, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Sharon Essink, Inge M. Zomerdijk, Thomas Goedecke, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Use of Reporting Recommendation Intended for Pharmaceutical Risk Minimisation Evaluation Studies (RIMES) Checklist in Risk Minimisation/Mitigation Studies: A Review and Survey
Samantha E Duckworth, Sophie Druelles, Emily Brouwer, et al.
Drug Safety (2024)
Closed Access | Times Cited: 1
Samantha E Duckworth, Sophie Druelles, Emily Brouwer, et al.
Drug Safety (2024)
Closed Access | Times Cited: 1
Comparing regulatory guidance on risk minimization/mitigation and the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies checklist
Sonia Guleria, Emily Brouwer, David Alan Brown, et al.
British Journal of Clinical Pharmacology (2024)
Closed Access
Sonia Guleria, Emily Brouwer, David Alan Brown, et al.
British Journal of Clinical Pharmacology (2024)
Closed Access